Human papillomavirus downregulates the expression of IFITM1 and RIPK3 to escape from IFNγ- and TNFα-mediated antiproliferative effects and necroptosis

Frontiers in Immunology

Volumn 7, Issue NOV, 2016, Pages

  Ma, Wenbo ^a   Tummers, Bart ^a   van Esch, Edith M G ^a   Goedemans, Renske ^a   Melief, Cornelis J M ^a   Meyers, Craig ^b   Boer, Judith M ^a,c   van der Burg, Sjoerd H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

HPV; Immune escape; Infection; Th1 cytokines

Indexed keywords

CELL SURFACE PROTEIN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; RECOMBINANT GAMMA INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL CYCLE ASSAY; CELL DEATH; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; DNA DETERMINATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE SILENCING; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MRNA EXPRESSION ASSAY; NECROPTOSIS; PAPILLOMAVIRUS INFECTION; PROTEIN EXPRESSION; REGULATORY MECHANISM; SPECTROFLUOROMETRY; WART VIRUS; WESTERN BLOTTING;

EID: 85006113125     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00496     Document Type: Article

References (60)

1. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 2(5):342-50. doi:10.1038/nrc798
2. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) (2006) 110(5):525-41. doi:10.1042/CS20050369
3. Tummers B, Burg SH. High-risk human papillomavirus targets crossroads in immune signaling. Viruses (2015) 7(5):2485-506. doi:10.3390/v7052485
4. Chang YE, Laimins LA. Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. J Virol (2000) 74(9):4174-82. doi:10.1128/JVI.74.9.4174-4182.2000
5. Nees M, Geoghegan JM, Hyman T, Frank S, Miller L, Woodworth CD. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. J Virol (2001) 75(9):4283-96. doi:10.1128/JVI.75.9.4283-4296.2001
6. Hong S, Mehta KP, Laimins LA. Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance. J Virol (2011) 85(18):9486-94. doi:10.1128/JVI.05007-11
7. Zhou F, Chen J, Zhao KN. Human papillomavirus 16-encoded E7 protein inhibits IFN-gamma-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes. J Gen Virol (2013) 94(Pt 11):2504-14. doi:10.1099/vir.0.054486-0
8. Huang SM, McCance DJ. Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF. J Virol (2002) 76(17):8710-21. doi:10.1128/JVI.76.17.8710-8721.2002
9. Avvakumov N, Torchia J, Mymryk JS. Interaction of the HPV E7 proteins with the pCAF acetyltransferase. Oncogene (2003) 22(25):3833-41. doi:10.1038/sj.onc.1206562
10. Bernat A, Avvakumov N, Mymryk JS, Banks L. Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300. Oncogene (2003) 22(39):7871-81. doi:10.1038/sj.onc.1206896
11. Havard L, Rahmouni S, Boniver J, Delvenne P. High levels of p105 (NFKB1) and p100 (NFKB2) proteins in HPV16-transformed keratinocytes: role of E6 and E7 oncoproteins. Virology (2005) 331(2):357-66. doi:10.1016/j.virol.2004.10.030
12. Caberg JH, Hubert P, Herman L, Herfs M, Roncarati P, Boniver J, et al. Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20. Cancer Immunol Immunother (2009) 58(1):39-47. doi:10.1007/s00262-008-0522-5
13. Karim R, Tummers B, Meyers C, Biryukov JL, Alam S, Backendorf C, et al. Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune response. PLoS Pathog (2013) 9(5):e1003384. doi:10.1371/journal.ppat.1003384
14. Tummers B, Goedemans R, Jha V, Meyers C, Melief CJ, van der Burg SH, et al. CD40-mediated amplification of local immunity by epithelial cells is impaired by HPV. J Invest Dermatol (2014) 134(12):2918-27. doi:10.1038/jid.2014.262
15. Tummers B, Goedemans R, Pelascini LP, Jordanova ES, van Esch EM, Meyers C, et al. The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFkappaB activation. Nat Commun (2015) 6:6537. doi:10.1038/ncomms7537
16. van der Burg SH, Melief CJ. Therapeutic vaccination against human papilloma virus induced malignancies. Curr Opin Immunol (2011) 23(2):252-7. doi:10.1016/j.coi.2010.12.010
17. Kenter GG, Welters MJ, Valentijn AR, Lowik MJ, Berends-van der Meer DM, Vloon AP, et al. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med (2009) 361(19):1838-47. doi:10.1056/NEJMoa0810097
18. Trimble CL, Morrow MP, Kraynyak KA, Shen X, Dallas M, Yan J, et al. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial. Lancet (2015) 386(10008):2078-88. doi:10.1016/S0140-6736(15)00239-1
19. van Poelgeest MI, Welters MJ, Vermeij R, Stynenbosch LF, Loof NM, Berends-van der Meer DM, et al. Vaccination against oncoproteins of HPV16 for noninvasive vulvar/vaginal lesions: lesion clearance is related to the strength of the T-cell response. Clin Cancer Res (2016) 22(10):2342-50. doi:10.1158/1078-0432.CCR-15-2594
20. Welters MJ, Kenter GG, de Vos van Steenwijk PJ, Lowik MJ, Berends-van der Meer DM, Essahsah F, et al. Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses. Proc Natl Acad Sci U S A (2010) 107(26):11895-9. doi:10.1073/pnas.1006500107
21. Platanias LC. Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat Rev Immunol (2005) 5(5):375-86. doi:10.1038/nri1604
22. Balachandran S, Adams GP. Interferon-gamma-induced necrosis: an antitumor biotherapeutic perspective. J Interferon Cytokine Res (2013) 33(4):171-80. doi:10.1089/jir.2012.0087
23. Thapa RJ, Nogusa S, Chen P, Maki JL, Lerro A, Andrake M, et al. Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc Natl Acad Sci U S A (2013) 110(33):E3109-18. doi:10.1073/pnas.1301218110
24. Cabal-Hierro L, Lazo PS. Signal transduction by tumor necrosis factor receptors. Cell Signal (2012) 24(6):1297-305. doi:10.1016/j.cellsig.2012.02.006
25. Detmar M, Orfanos CE. Tumor necrosis factor-alpha inhibits cell proliferation and induces class II antigens and cell adhesion molecules in cultured normal human keratinocytes in vitro. Arch Dermatol Res (1990) 282(4):238-45. doi:10.1007/BF00371643
26. Hancock GE, Kaplan G, Cohn ZA. Keratinocyte growth regulation by the products of immune cells. J Exp Med (1988) 168(4):1395-402. doi:10.1084/jem.168.4.1395
27. Saunders NA, Jetten AM. Control of growth regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon gamma. Antagonism by retinoic acid and transforming growth factor beta 1. J Biol Chem (1994) 269(3):2016-22.
28. Kono T, Tanii T, Furukawa M, Mizuno N, Taniguchi S, Ishii M, et al. Effects of human recombinant tumor necrosis factor-alpha (TNF-alpha) on the proliferative potential of human keratinocytes cultured in serum-free medium. J Dermatol (1990) 17(7):409-13. doi:10.1111/j.1346-8138.1990.tb01667.x
29. Viard-Leveugle I, Gaide O, Jankovic D, Feldmeyer L, Kerl K, Pickard C, et al. TNF-alpha and IFN-gamma are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis. J Invest Dermatol (2013) 133(2):489-98. doi:10.1038/jid.2012.330
30. Daehn IS, Varelias A, Rayner TE. T-lymphocyte-induced, Fas-mediated apoptosis is associated with early keratinocyte differentiation. Exp Dermatol (2010) 19(4):372-80. doi:10.1111/j.1600-0625.2009.00917.x
31. Karim R, Meyers C, Backendorf C, Ludigs K, Offringa R, van Ommen GJ, et al. Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes. PLoS One (2011) 6(3):e17848. doi:10.1371/journal.pone.0017848
32. Meyers C, Mayer TJ, Ozbun MA. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J Virol (1997) 71(10):7381-6.
33. McLaughlin-Drubin ME, Christensen ND, Meyers C. Propagation, infection, and neutralization of authentic HPV16 virus. Virology (2004) 322(2):213-9. doi:10.1016/j.virol.2004.02.011
34. Jones LJ, Gray M, Yue ST, Haugland RP, Singer VL. Sensitive determination of cell number using the CyQUANT cell proliferation assay. J Immunol Methods (2001) 254(1-2):85-98. doi:10.1016/S0022-1759(01)00404-5
35. Mulay SR, Desai J, Kumar SV, Eberhard JN, Thomasova D, Romoli S, et al. Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis. Nat Commun (2016) 7:10274. doi:10.1038/ncomms10274
36. Ohnishi S, Okabe K, Obata H, Otani K, Ishikane S, Ogino H, et al. Involvement of tazarotene-induced gene 1 in proliferation and differentiation of human adipose tissue-derived mesenchymal stem cells. Cell Prolif (2009) 42(3):309-16. doi:10.1111/j.1365-2184.2008.00592.x
37. Wu CC, Tsai FM, Shyu RY, Tsai YM, Wang CH, Jiang SY. G protein-coupled receptor kinase 5 mediates tazarotene-induced gene 1-induced growth suppression of human colon cancer cells. BMC Cancer (2011) 11:175. doi:10.1186/1471-2407-11-175
38. Han J, Zhong CQ, Zhang DW. Programmed necrosis: backup to and competitor with apoptosis in the immune system. Nat Immunol (2011) 12(12):1143-9. doi:10.1038/ni.2159
39. Wang L, Du F, Wang X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell (2008) 133(4):693-703. doi:10.1016/j.cell.2008.03.036
40. He S, Wang L, Miao L, Wang T, Du F, Zhao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell (2009) 137(6):1100-11. doi:10.1016/j.cell.2009.05.021
41. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol (2005) 1(2):112-9. doi:10.1038/nchembio711
42. Koo GB, Morgan MJ, Lee DG, Kim WJ, Yoon JH, Koo JS, et al. Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics. Cell Res (2015) 25(6):707-25. doi:10.1038/cr.2015.56
43. Hyland PL, McDade SS, McCloskey R, Dickson GJ, Arthur K, McCance DJ, et al. Evidence for alteration of EZH2, BMI1, and KDM6A and epigenetic reprogramming in human papillomavirus type 16 E6/E7-expressing keratinocytes. J Virol (2011) 85(21):10999-1006. doi:10.1128/JVI.00160-11
44. Sun S, Yu F, Zhang L, Zhou X. EZH2, an on-off valve in signal network of tumor cells. Cell Signal (2016) 28(5):481-7. doi:10.1016/j.cellsig.2016.02.004
45. Tan J, Yang X, Zhuang L, Jiang X, Chen W, Lee PL, et al. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev (2007) 21(9):1050-63. doi:10.1101/gad.1524107
46. Miranda TB, Cortez CC, Yoo CB, Liang G, Abe M, Kelly TK, et al. DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol Cancer Ther (2009) 8(6):1579-88. doi:10.1158/1535-7163.MCT-09-0013
47. Yang G, Xu Y, Chen X, Hu G. IFITM1 plays an essential role in the antiproliferative action of interferon-gamma. Oncogene (2007) 26(4):594-603. doi:10.1038/sj.onc.1209807
48. Friedman RL, Manly SP, McMahon M, Kerr IM, Stark GR. Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell (1984) 38(3):745-55. doi:10.1016/0092-8674(84)90270-8
49. Kelly JM, Gilbert CS, Stark GR, Kerr IM. Differential regulation of interferon-induced mRNAs and c-myc mRNA by alpha-and gamma-interferons. Eur J Biochem (1985) 153(2):367-71. doi:10.1111/j.1432-1033.1985.tb09312.x
50. Ackrill AM, Reid LE, Gilbert CS, Gewert DR, Porter AC, Lewin AR, et al. Differential response of the human 6-16 and 9-27 genes to alpha and gamma interferons. Nucleic Acids Res (1991) 19(3):591-8. doi:10.1093/nar/19.3.591
51. Muller M, Laxton C, Briscoe J, Schindler C, Improta T, Darnell JE Jr, et al. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and-gamma signal transduction pathways. EMBO J (1993) 12(11):4221-8.
52. Hamid NA, Brown C, Gaston K. The regulation of cell proliferation by the papillomavirus early proteins. Cell Mol Life Sci (2009) 66(10):1700-17. doi:10.1007/s00018-009-8631-7
53. Fuentes-Gonzalez AM, Contreras-Paredes A, Manzo-Merino J, Lizano M. The modulation of apoptosis by oncogenic viruses. Virol J (2013) 10:182. doi:10.1186/1743-422X-10-182
54. Mocarski ES, Upton JW, Kaiser WJ. Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat Rev Immunol (2012) 12(2):79-88. doi:10.1038/nri3131
55. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell (2009) 137(6):1112-23. doi:10.1016/j.cell.2009.05.037
56. Huang Z, Wu SQ, Liang Y, Zhou X, Chen W, Li L, et al. RIP1/RIP3 binding to HSV-1 ICP6 initiates necroptosis to restrict virus propagation in mice. Cell Host Microbe (2015) 17(2):229-42. doi:10.1016/j.chom.2015.01.002
57. Upton JW, Kaiser WJ, Mocarski ES. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe (2010) 7(4):302-13. doi:10.1016/j.chom.2010.03.006
58. Bhanja Chowdhury J, Shrivastava S, Steele R, Di Bisceglie AM, Ray R, Ray RB. Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A. J Virol (2012) 86(18):10221-5. doi:10.1128/JVI.00882-12
59. Wee ZN, Li Z, Lee PL, Lee ST, Lim YP, Yu Q. EZH2-mediated inactivation of IFN-gamma-JAK-STAT1 signaling is an effective therapeutic target in MYC-driven prostate cancer. Cell Rep (2014) 8(1):204-16. doi:10.1016/j.celrep.2014.05.045
60. Zhang L, Wu J, Ling MT, Zhao L, Zhao KN. The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses. Mol Cancer (2015) 14:87. doi:10.1186/s12943-015-0361-x